ASTRONICS CORP

ATROB

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 666,498Value: $36.2M

**Signal Note: Driehaus Capital enters ATROB** This signal appears misaligned with Driehaus's stated biotech focus—Astronics Corp is an aerospace/defense electronics supplier with no drug pipeline or clinical programs. The $36.2M position likely reflects either a data error in the filing, a strategic pivot into aerospace exposure, or a portfolio manager's conviction in valuation/operational turnaround rather than biotech catalysts. Without confirmed biotech assets or clinical milestones, this warrants clarification on investment thesis before drawing sector conclusions.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: